Got nasopharyngeal carcinoma early how long can live

Update Date: 2021-07-15 Source: Network

summary

Not long ago, my uncle found out that he suffered from nasopharyngeal carcinoma and went to the hospital for surgical treatment. Now his condition has been controlled to a certain extent. Patients with nasopharyngeal carcinoma must be found early and treated early to avoid causing more serious harm to the body. At the beginning, the doctor also told us about how long they can live in the early stage of nasopharyngeal carcinoma.

Got nasopharyngeal carcinoma early how long can live

First of all: for patients with nasopharyngeal carcinoma, how long they can live in the early stage mainly depends on whether appropriate treatment is taken in time. The most important treatment for early nasopharyngeal carcinoma is radiotherapy. The 5-year survival rate after early treatment is more than 70%.

Secondly, the clinical effect of nasopharyngeal carcinoma treatment is good, and the survival period of patients is extended. Many patients have successfully passed the 5-year survival period after treatment. In short, nasopharyngeal carcinoma does not mean death, as long as we can do early detection, and take effective and reasonable treatment, we can effectively control cancer.

Finally, the natural course of NPC from initial symptoms to death ranged from 3 months to 13 months. According to reports at home and abroad, the 5-year survival rate after radiotherapy is 8% - 62%. With the update of radiotherapy equipment and the improvement of radiotherapy technology, the 5-year survival rate of nasopharyngeal carcinoma after radiotherapy continues to improve.

matters needing attention

In daily life, patients should timely correct bad living habits, have a positive and optimistic attitude to treat this disease, to extend the survival period of patients with nasopharyngeal carcinoma, we need to pay attention to the reasonable combination of traditional Chinese medicine in the process of Western medicine treatment of nasopharyngeal carcinoma, enhance the patient's resistance, anti-inflammatory and analgesic.